Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Simcere will develop a cardiovascular...
Fosun Pharma has bought another slice of...
Two high-visibility generic drug JVs between east and...
Simcere Pharma was given SFDA approval...
Simcere Pharma has sold its 35% stake in...
Simcere Pharma, a Nanjing maker of...
Simcere Pharma, like many US-listed...
Hony Capital, the China-based private equity firm that is...
In 2011, the world’s two largest drugmakers –...
Zhejiang Hisun Pharma contributed 75 drug products to...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
